Back to Journals » OncoTargets and Therapy » Volume 9

History and progression of Fat cadherins in health and disease

Authors Zhang X, Liu J, Liang X, Chen J, Hong J, Li L, He Q, Cai X

Received 22 April 2016

Accepted for publication 11 October 2016

Published 1 December 2016 Volume 2016:9 Pages 7337—7343


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Ram Prasad

Peer reviewer comments 2

Editor who approved publication: Dr Faris Farassati

Xiaofeng Zhang,1,2,* Jinghua Liu,3,* Xiao Liang,1,2 Jiang Chen,1,2 Junjie Hong,1,2 Libo Li,1 Qiang He,3 Xiujun Cai1,2

1Department of General Surgery, 2Key Laboratory of Surgery of Zhejiang Province, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, 3Department of Hepatobiliary Surgery, Linyi People’s Hospital, Linyi, Shandong, People’s Republic of China

*These authors contribute equally to this work

Intercellular adhesions are vital hubs for signaling pathways during multicellular development and animal morphogenesis. In eukaryotes, under aberrant intracellular conditions, cadherins are abnormally regulated, which can result in cellular pathologies such as carcinoma, kidney disease, and autoimmune diseases. As a member of the Ca2+-dependent adhesion superfamily, Fat proteins were first described in the 1920s as an inheritable lethal mutant phenotype in Drosophila, consisting of four member proteins, FAT1, FAT2, FAT3, and FAT4, all of which are highly conserved in structure. Functionally, FAT1 was found to regulate cell migration and growth control through specific protein–protein interactions of its cytoplasmic tail. FAT2 and FAT3 are relatively less studied and are thought to participate in the development of human cancer through a pathway similar to that of the Ena/VASP proteins. In contrast, FAT4 has been widely studied in the context of biological functions and tumor mechanisms and has been shown to regulate the planar cell polarity pathway, the Hippo signaling pathway, the canonical Wnt signaling cascade, and the expression of YAP1. Overall, Fat cadherins may be useful as emerging disease biomarkers and as novel therapeutic targets.

Fat cadherins, FAT1, FAT2, FAT3, FAT4, CpG island, Hippo pathway, WNT signaling

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]